On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo

Neuroendocrinology Letters

Volumn 27, Issue SUPPL. 2, 2006, Pages 138-140

  Drábiková, Katarína ^a   Jančinová, Viera ^a   Nosál', Radomír ^a   Solík, Peter ^b   Murín, Ján ^b   Holomáňová, Dagmar ^c  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c National Blood Transfusion Service   (Slovakia)

Author keywords

Carvedilol; Chemiluminescence; Congestive heart failure; Isolated polymorphonuclear leukocytes; Reactive oxygen metabolites generation; Whole blood

Indexed keywords

CARVEDILOL; LUMINOL; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; CASE REPORT; CELL ISOLATION; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEVICE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 34047199257     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Butler S, Wang R, Wunder SL, Cheng HY, Randall CS. Perturbing effects of carvedilol on a model membrane system: Role of lipophilicity and chemical structure. Biophys Chem 2006; 119(3):307-15.
2. Djanani A, Kaneider NC, Meierhofer Ch, Sturn D, Dunzendorfer S, Allmeier H, Wiedermann CJ. Inhibition of neutrophil migration and oxygen free radical release by metipranolol and timolol. Pharmacology 2003; 68(4):198-203.
3. Jacob S, Rett K, Heuriksen EJ. Antihypertensive therapy and insulin sensitivity. Do we have to redefine the role of beta-blocking agents? Am J Hypertens 1998; 11(10):1258-65.
4. Jančinová V, Drábiková K, Nosál' R, Májeková M, Račková L, Holomáňová D. Antiradical effects of antihistamines in human blood. Structure-activity relationship. Inflamm Res 2006; 55(Suppl 1): S85-6.
5. Jančinová V, Drábiková K, Nosál' R, Račková L, Májeková M, Holomáňová D. The combined luminol/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils. Redox Rep 2006; 11(3):110-6.
6. Karlsson A, Dahlgren C. Assembly and Activation of Neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 2002; 5(1):49-60.
7. Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang Cs. Importance of antioxidant and antiapoptic effects of beta-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2004; 287(3):H1003-12.
8. Kowalski J, Błaszczyk J, Petecka E, Irmański R, Kowalcyzk E, Kowalska E, Cegliński T, Pawlicki L. Neutrophils superoxide anion generation during carvedilol therapy in patients with stable angina. Int J Cardiol 2005; 102(3):397-402.
9. Nosál' R, Jančinová V, Číž M, Drábiková K, Lojek A, Fabryová V. Inhibition of chemiluminescence of carvedilol in the cell-free system, whole blood and blood cells. Scand J Clin Lab Invest 2005; 65(1):55-64.
10. Pečivová J, Mačičková T, Lojek A, Gallová L, Číž M, Nosál' R. The effect of carvedilol on respiratory burst of phagocytes in vitro. J FEBS 2005; 272:(Suppl.1) D3-022P.
11. Petríková M, Jančinová V, Nosál' R, Májeková M, Danihelová E. Antiplatelet activity of carvedilol in comparison to propranolol. Platelets 2002; 13(8):479-85.